Susumu Ishida Selected Research

Susumu Ishida Research Topics

Disease

53	Inflammation (Inflammations) 04/2022 - 02/2004
44	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2022 - 05/2003
28	Neoplasms (Cancer) 12/2022 - 12/2010
25	Uveitis 05/2022 - 06/2004
22	Choroidal Neovascularization 07/2020 - 10/2006
19	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2007
12	Epiretinal Membrane (Epiretinal Membranes) 01/2017 - 02/2002
10	Hypoxia (Hypoxemia) 07/2021 - 08/2003
10	Cataract (Cataracts) 07/2020 - 11/2004
10	Retinal Perforations 01/2017 - 02/2002
9	Retinal Detachment (Retinal Detachments) 09/2022 - 02/2002
9	Glaucoma 01/2022 - 01/2008
7	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 05/2022 - 04/2015
7	Fibrosis (Cirrhosis) 01/2021 - 01/2013
7	White Dot Syndromes 06/2019 - 01/2012
7	Macular Edema 11/2017 - 06/2004
6	Retinal Hemorrhage 04/2022 - 01/2011
5	Lymphoma (Lymphomas) 10/2022 - 06/2004
5	Neovascular Glaucoma 03/2022 - 01/2008
5	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2022 - 08/2012
5	Retinal Neovascularization 01/2016 - 08/2003
5	Pathologic Neovascularization 08/2013 - 06/2003
4	Retinal Degeneration 09/2022 - 05/2008
4	Retinal Vein Occlusion 03/2022 - 05/2009
4	Ischemia 03/2022 - 06/2003
4	Cicatrix (Scar) 03/2022 - 10/2004
4	Ganglion Cysts (Ganglion) 09/2021 - 09/2012
4	Melanoma (Melanoma, Malignant) 07/2021 - 11/2011
4	Hemorrhage 05/2019 - 01/2008
4	Wounds and Injuries (Trauma) 06/2017 - 08/2007
4	Retinal Vasculitis 01/2015 - 09/2012
3	Intraocular Lymphoma 10/2022 - 06/2004
3	Sarcoidosis (Schaumann Disease) 05/2022 - 01/2010
3	Vitreous Hemorrhage 03/2022 - 09/2012
3	Vitreous Detachment (Posterior Vitreous Detachment) 01/2018 - 02/2007
3	Burns 05/2017 - 05/2008
3	Retinal Diseases 01/2017 - 03/2009
3	Atopic Dermatitis (Atopic Eczema) 01/2017 - 10/2005
3	Pterygium 08/2016 - 01/2011
3	Atrophy 01/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

59	Retinaldehyde (Retinal)IBA 09/2022 - 02/2002
34	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2003
13	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2006
13	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2019 - 05/2009
13	EndotoxinsIBA 01/2014 - 08/2005
11	ReninIBA 07/2020 - 06/2006
11	Type 1 Angiotensin ReceptorIBA 01/2013 - 03/2005
10	Prorenin ReceptorIBA 09/2019 - 06/2006
7	Prednisolone (Predate)FDA LinkGeneric 03/2022 - 09/2012
7	Galectin 1 (LGALS1)IBA 01/2021 - 12/2015
6	Fluorescein (Funduscein)FDA LinkGeneric 09/2022 - 07/2005
6	Crystallins (Crystallin)IBA 04/2022 - 10/2011
6	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2021 - 02/2002
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2021 - 02/2004
6	Therapeutic UsesIBA 10/2020 - 12/2006
6	Bevacizumab (Avastin)FDA Link 03/2018 - 01/2011
6	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2009 - 05/2003
5	Advanced Glycation End ProductsIBA 04/2022 - 02/2007
5	AntibodiesIBA 10/2021 - 12/2009
5	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2020 - 02/2007
5	Biological ProductsIBA 01/2019 - 05/2012
5	CytokinesIBA 06/2017 - 03/2007
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2010
4	Acrolein (Aqualin)IBA 01/2021 - 01/2017
4	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2020 - 12/2015
4	Ophthalmic Solutions (Eye Drops)IBA 11/2019 - 11/2011
4	InterleukinsIBA 10/2019 - 06/2007
4	Peptides (Polypeptides)IBA 12/2016 - 06/2006
4	Oxygen (Dioxygen)IBA 08/2013 - 11/2004
4	Cell Adhesion MoleculesIBA 01/2013 - 03/2009
4	Telmisartan (Micardis)FDA Link 05/2009 - 03/2005
4	Interleukin-6 (Interleukin 6)IBA 09/2008 - 06/2004
3	Coloring Agents (Dyes)IBA 09/2022 - 05/2019
3	Pharmaceutical PreparationsIBA 09/2022 - 09/2016
3	SteroidsIBA 02/2022 - 11/2016
3	Vascular Endothelial Growth Factor CIBA 07/2021 - 02/2013
3	Interleukin-10 (Interleukin 10)IBA 05/2021 - 06/2004
3	Protein Isoforms (Isoforms)IBA 01/2021 - 05/2003
3	EnzymesIBA 07/2020 - 01/2013
3	AldehydesIBA 01/2020 - 01/2017
3	InterferonsIBA 11/2019 - 11/2011
3	ParaffinIBA 06/2017 - 12/2009
3	Infliximab (Remicade)FDA Link 01/2016 - 07/2012
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2013 - 10/2005
3	Monocyte Chemoattractant ProteinsIBA 01/2013 - 06/2007
3	LuteinIBA 05/2012 - 12/2007
3	ResveratrolIBA 11/2011 - 07/2009

Therapy/Procedure

28	Therapeutics 06/2022 - 01/2011
25	Vitrectomy 04/2022 - 02/2002
22	Lasers (Laser) 10/2020 - 04/2002
7	Intravitreal Injections 07/2020 - 01/2011
6	Trabeculectomy (Trabeculoplasty) 01/2022 - 08/2012
5	Drug Therapy (Chemotherapy) 04/2022 - 01/2014
5	Light Coagulation 05/2019 - 01/2008
4	Sutures (Suture) 01/2022 - 08/2012
4	Radiotherapy 07/2020 - 05/2011
4	Slit Lamp 01/2020 - 12/2010
4	Intraocular Lens Implantation 01/2017 - 10/2005
4	Cannula 07/2008 - 11/2004
3	Injections 01/2017 - 05/2003